Vaxcyte, Inc. (PCVX)
45.34
-0.84
(-1.82%)
USD |
NASDAQ |
Dec 09, 13:21
Vaxcyte Market Cap: 5.935B for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Thermo Fisher Scientific, Inc. | 212.34B |
| Novavax, Inc. | 1.103B |
| Pfizer Inc. | 145.21B |
| Moderna, Inc. | 11.03B |
| Eli Lilly & Co. | 888.77B |
Market Cap Related Metrics
| PEG Ratio | -1.767 |
| Price to Book Value | 2.052 |
| Price | 45.34 |
| Earnings Yield | -10.86% |
| PEGY Ratio | -1.767 |